Colorado Springs, Colorado 2021-05-05 05:01:00 –
Morgan Wolf woke up on the morning of April 12 with the most severe headache he had ever experienced.
The room has rotated. She could hardly get out of bed.
She was excited to get the Johnson & Johnson Coronavirus vaccine two weeks ago, and the minor pain she felt after the shot disappeared immediately. However, a week after the injection, a 40-year-old woman from Denver felt sick again and her symptoms only worsened.
Lying on the bed on April 12, she made a plan: if she didn’t get better by the next day, she went to the emergency room.
What’s New from the Coronavirus Outbreak in Colorado:
- Live blog: Updates on closures, restrictions and other major updates.
- map: Cases and deaths in Colorado.
- test: The community test site is here.The state is Encourage now People with symptoms to take the test.
- Vaccine hotline: Get the latest information.
- story: Cases of Colorado coronavirus are on the rise, especially among people under the age of 18, and hospitalizations are also on the rise.
That same day, R. at the UC Health University of Colorado Hospital, a few miles away. Dr. Todd Clark met with a hospital hematologist to discuss reports of ultra-rare blood clots associated with the AstraZeneca-produced coronavirus vaccine. The vaccine uses the same technology as the Johnson & Johnson vaccine, so the two doctors asked:
Clark, an emergency medical expert, said:
The next morning, Wolf went to the hospital. Her phone was buzzing with news that federal regulators recommended suspending use of the Johnson & Johnson vaccine after six reports of blood clots similar to what she was experiencing. I did. Clark and the other doctors were ready immediately when she arrived.
“It’s perfectly reasonable to say that if she appeared three days ago, she might not have had the kind of work-up she did,” Clark said.
Instead, what happened was a textbook case where the country’s vaccine safety surveillance system was working properly, Clark said. And Wolff said her support for the coronavirus vaccine remained undiminished — she said she should have received another, of course, even for the Johnson & Johnson vaccine.
“Despite everything that happened, I definitely think it’s important to continue to promote vaccination in as many countries and as many of the world as possible,” Wolff said. “Obviously, I had a bad reaction to this, and that’s a shame for me, but I still think there’s a place for it in the overall strategy.”
Identifying rare side effects
there were About 40,000 people In the final clinical trial of Johnson & Johnson vaccine. This is enough to identify more common side effects such as headaches and malaise. However, it is not enough to always detect rare side effects such as blood clots before the vaccine is approved for widespread use.
That’s why the federal government depends Large and open reporting system This allows most people to submit almost anything unconfirmed reports. Doctors at the Centers for Disease Control and Prevention examine reports and look for patterns. The pattern was found in the following rare coagulation states: Cerebral vein sinus thrombosis with thrombocytopenia Related to Johnson & Johnson Vaccine.
Clark said federal warnings and early reports of blood clots from a similar AstraZeneca vaccine were invaluable to doctors at the University of Colorado Hospital. Otherwise, with the symptoms she had, Wolf was probably first treated in the emergency department for a viral infection or dehydration.
Instead, the doctor immediately performed her blood test to see if she was in a coagulated state, then moved her to scan and check for the presence of blood clots. In addition to providing insight into how Wolf’s care is done, these pretreatment blood tests are valuable to researchers who want to better understand why this condition occurs in the first place, according to Clark. There is.
In addition, federal warnings have given doctors another important piece of information. A common drug for treating blood clots called heparin is that it should not be used to treat blood clots associated with the Johnson & Johnson vaccine. Even worse. That’s why doctors at the University of Colorado Hospital used another drug called bivalirudin to treat Wolf.
It worked and gave the first known example in the country of doctors using drugs for Johnson & Johnson blood clots.Clark and his colleagues I wrote a research treatise on it..
For Clark, the experience was encouraging and even uplifting — it’s like he went into medicine.
“This is not the story of a scary person,” he said. “This is a story that gives people confidence. It’s a success. It’s all working.”
Return to normal
Wolf spent six days in the hospital to recover from a blood clot. Since she has been released, she is still taking medicine to dissolve the blood clot, and she also needs to ease it for a while. The blood clots that remain in her lungs mean she gets tired easily. She can’t work on small landscaping projects or her beloved tree planting projects around Denver.
But she also wants better days for both herself and the community. She is eager to participate in the study so that doctors can identify who is at risk for blood clots. (All cases identified so far have occurred in women between the ages of 18 and 60.) She hopes that information will regain some confidence in the Johnson & Johnson vaccine.
And while she’s curious about what caused the reaction, she doesn’t often wonder why it hit her.was there 12 confirmed cases Of the nearly 8 million doses of Johnson & Johnson vaccine, so far it is in a national state.
“I just want to focus on getting better and getting better,” she said. “I don’t think,’Oh, why me?’ It’s always the most productive way to move forward.”
Colorado Sun does not have paywalls. This means readers don’t have to pay to access articles. We believe that affected people need to identify important information, such as public health crises, investigative journalism, and parliamentary accountability.
This report Depends For support from readers like you. Invest in an informed community for just $ 5 a month.
A Colorado woman developed rare blood clots from a coronavirus vaccine. She says you should still get vaccinated. Source link A Colorado woman developed rare blood clots from a coronavirus vaccine. She says you should still get vaccinated.